This presentation was new, inspiring, informative educational and challenging. It has opened up new vistas for education in general, and for remote/virtual learning in particular. It has made an "old " teacher young or rather "Younger" again. I feel as enthusiastic as when I first started teaching, many moons ago.
keynote180.com was registered 6 years 7 months ago. It has a alexa rank of #5,936,123 in the world. It is a domain having .com extension. It is estimated worth of $ 240.00 and have a daily income of around $ 1.00. As no active threats were reported recently, keynote180.com is SAFE to browse.
Daily Unique Visitors: | 148 |
Daily Pageviews: | 296 |
Income Per Day: | $ 1.00 |
Estimated Worth: | $ 240.00 |
Google Indexed Pages: | Not Applicable |
Yahoo Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Alexa BackLinks: | Not Applicable |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: |
![]() |
WOT Privacy: |
![]() |
WOT Child Safety: |
![]() |
Alexa Rank: | 5,936,123 |
PageSpeed Score: | 89 ON 100 |
Domain Authority: |
49 ON 100 ![]() |
Bounce Rate: | Not Applicable |
Time On Site: | Not Applicable |
Teacher Training | Online Teaching | Leadership Training | Keynote 180 | Professional Development
Apr 01, 2019 · The KEYNOTE-180 study is a global, open-label, phase 2 study of pembrolizumab for patients with histologically confirmed advanced and metastatic esophageal...
KEYNOTE-181 was a randomized, open-label, active-controlled trial that enrolled 628 patients with recurrent locally advanced or metastatic esophageal cancer who progressed on or...
First-line pembrolizumab plus pemetrexed-platinum continued to demonstrate substantially improved OS and PFS in metastatic nonsquamous NSCLC, regardless of PD-L1 expression or...
Sep 24, 2015 · Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180)...
Our study demonstrates the clinical benefit of anti-programmed death-1 therapy with pembrolizumab among patients with previously treated unresectable or metastatic MSI-H/dMMR...
2 Background: Patients with advanced esophageal cancer after first-line chemotherapy (chemo) have a poor prognosis and limited treatment options. We present results of the phase...
CALL: +1-973-531-READ (7323) [email protected]. Teacher Training. Team Development. Youth Leadership. Articles & Interviews. More. Dr. H. M. Saleem. Dr. H. M. Saleem has...
CALL: +1-973-531-READ (7323) [email protected] Teacher Training. Team Development
Keynote 180, Woodbridge, New Jersey. 44 likes · 1 talking about this. On this page, Dr. Saleem discusses personal and professional issues of contemporary concerns to help us...
Spotify. Episode #102: Our Culture of Conspiracy Theories
We would like to show you a description here but the site won’t allow us.
KEYNOTE-180 was a phase 2 clinical trial that enrolled 121 patients with advanced, metastatic esophageal cancer that had progressed after two or more lines of standard therapy....
4049 Background: Effective therapy for patients (pts) with metastatic esophageal cancer progressing after at least 2 lines of prior therapy is an unmet need. The phase 2,...
TPS4140 Background: Tumors can hijack the PD-1 pathway to suppress immune control. Overexpression of the PD-1 ligand PD-L1 in esophageal cancer may be associated with a poor...
Our study demonstrates the clinical benefit of anti-programmed death-1 therapy with pembrolizumab among patients with previously treated unresectable or metastatic MSI-H/dMMR...
基于keynote-028和keynote-180研究中帕博利珠单抗显示的食管癌治疗前景,研究者进一步开展了iii期keynote-181研究,在晚期或转移性食管鳞癌或腺癌/siewert i型食管胃结合部腺癌患者的二线治疗中,头对头比较帕博利珠单抗与研究者选择的化疗。
Nov 01, 2019 · ABSTRACTS Gastrointestinal tumours, non-colorectal 124O KEYNOTE-181: Pembrolizumab vs chemotherapy in patients (pts) with advanced/metastatic adenocarcinoma (AC)...
TARGETED ONCOLOGY:Please provide some background to the KEYNOTE-180 trial. Shah:Esophageal cancer is a deadly disease. Unfortunately, most patients with metastatic disease die...
Background: Advanced recurrent ovarian cancer (ROC) is the leading cause of gynecologic cancer-related death in developed countries and new treatments are needed. Previous...
Sep 30, 2015 · In this study, participants with advanced or metastatic adenocarcinoma or squamous cell carcinoma of the esophagus or Siewert type I adenocarcinoma of the...
H1 Headings: | 1 | H2 Headings: | 19 |
H3 Headings: | 3 | H4 Headings: | Not Applicable |
H5 Headings: | 4 | H6 Headings: | 1 |
Total IFRAMEs: | 3 | Total Images: | 27 |
Google Adsense: | Not Applicable | Google Analytics: | UA-172811670-1 |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
Online Teaching | 7 | 0.971 % | No |
LEVEL I | 3 | 0.416 % | No |
student feedback | 3 | 0.416 % | No |
Play Video | 3 | 0.416 % | No |
Shall I | 3 | 0.416 % | No |
to engage | 3 | 0.416 % | No |
online teaching | 3 | 0.416 % | No |
How to | 3 | 0.416 % | No |
Effective Online | 3 | 0.416 % | No |
Dr Saleem | 2 | 0.277 % | No |
Teaching The | 2 | 0.277 % | No |
LEVEL II | 2 | 0.277 % | No |
for students | 2 | 0.277 % | No |
Do I | 2 | 0.277 % | No |
How Do | 2 | 0.277 % | No |
Optional LEVEL | 2 | 0.277 % | No |
Keynote 180 | 2 | 0.277 % | No |
For Effective | 2 | 0.277 % | No |
has been | 2 | 0.277 % | No |
And The | 2 | 0.277 % | No |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
Playing WTSD LIVE Interactive | 2 | 0.277 % | No |
WTSD LIVE Interactive Workshop | 2 | 0.277 % | No |
Now Playing WTSD LIVE | 2 | 0.277 % | No |
For Effective Online Teaching | 2 | 0.277 % | No |
engaging online lessons Lecture | 2 | 0.277 % | No |
Effective Online Teaching Learning | 2 | 0.277 % | No |
tutorials on online teaching | 2 | 0.277 % | No |
Tools Shall I Use | 2 | 0.277 % | No |
Dr H M Saleem | 2 | 0.277 % | No |
certification programs Networking with | 1 | 0.139 % | No |
programs Networking with other | 1 | 0.139 % | No |
Networking with other online | 1 | 0.139 % | No |
and certification programs Networking | 1 | 0.139 % | No |
workshops and certification programs | 1 | 0.139 % | No |
teaching workshops and certification | 1 | 0.139 % | No |
conferences Inschool or indistrict | 1 | 0.139 % | No |
technology conferences Inschool or | 1 | 0.139 % | No |
with other online teachers | 1 | 0.139 % | No |
Online teaching workshops and | 1 | 0.139 % | No |
via established technology educational | 1 | 0.139 % | No |
UygunEhliyet.com ile İş Makinası, Forklift, Vinç Ehliyeti ve daha fazlasını uygun fiyatlarla alın. Sınav tarihleri, fiyatlar ve gerekli evraklar hakkında bilgi edinin.
Woodend Building Design is an architectural design service, specialising in custom home designs. We work with you to design the project of your dreams.
Sure, here’s a site description for Google: Knowledge Bridge offers specialized continuing education and career advancement courses for physiotherapists and physical therapists...
At YDY Professional Construction, we understand that your home is more than just a place to live it's a reflection of your personal style and the backdrop for your daily life....
Domain Registrar: |
GoDaddy.com, LLC
![]() |
---|---|
Registration Date: | 2018-09-05 6 years 7 months 18 hours ago |
Last Modified: | 2020-09-05 4 years 6 months 4 weeks ago |
Host | IP Address | Country | |
---|---|---|---|
ns6.wixdns.net | ![]() |
216.239.32.100 | ![]() |
ns7.wixdns.net | ![]() |
216.239.34.100 | ![]() |
Host | Type | TTL | Extra |
---|---|---|---|
keynote180.com | A | 3480 |
IP: 185.230.63.186 |
keynote180.com | A | 3480 |
IP: 185.230.63.107 |
keynote180.com | A | 3480 |
IP: 185.230.63.171 |
keynote180.com | NS | 86400 |
Target: ns6.wixdns.net |
keynote180.com | NS | 86400 |
Target: ns7.wixdns.net |
keynote180.com | SOA | 3600 |
MNAME: ns6.wixdns.net RNAME: support.wix.com Serial: 2018092304 Refresh: 10800 Retry: 3600 Expire: 604800 |
keynote180.com | MX | 3600 |
Priority: 50 Target: alt4.aspmx.l.google.com |
keynote180.com | MX | 3600 |
Priority: 10 Target: aspmx.l.google.com |
keynote180.com | MX | 3600 |
Priority: 20 Target: alt1.aspmx.l.google.com |
keynote180.com | MX | 3600 |
Priority: 30 Target: alt2.aspmx.l.google.com |
keynote180.com | MX | 3600 |
Priority: 40 Target: alt3.aspmx.l.google.com |
keynote180.com | TXT | 3600 |
TXT: google-site-verification=upkNIeiPwE5Gyg_ GEjpu-CHh18JPPSn3fB-TqByWcpQ |
Info-Pflege.de - Ihr Portal für Altenpflege und Krankenpflege Info-Pflege.de: Ihr Info-Portal für die Pflegedienste und Altenpflege und Krankenpflege: Info-Pflege: Das Portal...
Your personal roadmap to incredible relationships with your friends, family, roommates, teammates and potential soulmate. Discover the Science of You.
Tutustu toimittajien, jakelijoiden ja valmistajien uusimpiin katalogeihin EUROPAGES-sivustolla.
Chicago writer, author, journalist David M. Freedman. Focusing on finance, law, equity crowdfunding, woodworking, box-making, angel investing, great lakes highland park
Shop for any type of sign for business, office, informational, promotional, safety, retail, street advertising, also vehicle decals, trade-show displays, banners, and more.